UFF
SNV

USA Financial Formulas’s Synovus SNV Stock Holding History

USA Financial Formulas’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,720
Closed -$339K – 472
2021
Q2 		$339K Buy
7,720
+1,531
+25% +$71.9K 0.28% 104
2021
Q1 		$283K Buy
+6,189
New +$259K 0.23% 111

Other funds holding SNV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

USA Financial Formulas's SNV Position: Q3 2021 in Review

USA Financial Formulas sold out of Synovus (SNV) in Q3 2021, closing a stake of 7,720 shares — an estimated $339K sold.

USA Financial Formulas first reported a position in SNV in Q1 2021 and held it in 2 quarters. The position peaked at $339K in Q2 2021. 386 funds tracked by Wall St. Rank hold SNV as of Q3 2021.

  • USA Financial Formulas reported no remaining Synovus position as of Q3 2021 after selling out during the quarter.
  • USA Financial Formulas sold 7,720 Synovus shares in Q3 2021, an estimated $339K.
  • USA Financial Formulas first reported a position in Synovus in Q1 2021 and held it in 2 quarters.
  • USA Financial Formulas's Synovus position peaked at $339K in Q2 2021.
  • 386 funds tracked by Wall St. Rank held Synovus as of Q3 2021.

Based on USA Financial Formulas's 13F filing for Q3 2021, filed 8 Nov 2021.